Axsome Therapeutics Earnings Perspective: Return On Capital Employed By: Benzinga via Benzinga March 02, 2023 at 09:49 AM EST Axsome Therapeutics (NASDAQ:AXSM) brought in sales totaling $24.37 million during Q4 according to data provided by Benzinga Pro. ... Read More >> Related Stocks: Axsome Thera